🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Massachusetts

128 posts
Read More

Azenta (AZTA) expands GENEWIZ with SynPlexity acquisition and $71m potential Elegen commitment

Azenta is expanding its GENEWIZ gene synthesis business through the completed acquisition of SynPlexity and an exclusive technology agreement with Elegen. Regulatory filings reveal potential capital commitments of $32 million to $71 million under the Elegen arrangements, raising questions about technology integration, commercial adoption and investment returns as Azenta works to improve its Multiomics business.